Constance Finley's Story


Constance Finley, Founder and CEO of Constance CBD, was inspired by her own personal experience with chronic illness

After nearly dying from the pharmaceuticals prescribed to help alleviate pain and inflammation caused by a rare autoimmune disease, Finley turned to Full Spectrum CBD Extract for relief.

She quickly became fascinated with the science behind the medicinal benefits of cannabis. Studies have found that cannabinoids, like THC and CBD, are more effective when working in tandem with the entire phytochemical profile of the female cannabis flower versus working in isolation – what is known as “The Entourage Effect.” Based on her research, Finley became determined to make standardized, whole plant CBD extracts that incorporate all the naturally occurring
cannabinoids, terpenes and flavonoids in cannabis, and are safe for those with compromised immune systems.


CT was the first CBD company to offer known genetics, standardized formulations from multiple botanical inputs and standardized operating procedures, including third party verified quality controls, along all stages of the cultivation and manufacturing processes

Prior to Constance CBD, Finley was founder and CEO of Constance Therapeutic Inc Housing Allies, Inc. She pioneered the use of tax credits to create high-quality, aesthetically delightful low-income housing for the working poor and ill, utilizing corporate investments motivated by financial tax benefits. Finley also worked as a clinical psychologist and taught psychology courses at Naropa University, Greeley Junior College and Lone Mountain College. She holds a Master of Arts in Clinical Psychology from the University of San Francisco, where she graduated first in her class, and a Bachelor of Arts in Eastern Studies and Psychology from Lone Mountain College, where she graduated summa cum laude. Finley sits on various advisory boards, including an assignment to the Scientific Advisory Board for CannaTech.

Constance CBD – San Francisco Bay Area, California.

DISCLAIMER: These statements have not been evaluated by the United States Food and Drug Administration. The U.S. federal government (including the FDA) maintains that cannabis is a Schedule 1 drug under the federal Controlled Substances Act, with no accepted medical use, despite the mounting evidence from the international medical community. As a result, our products cannot go through FDA testing that would enable us to make health claims, and we are required to state that Constance CBD products are not intended to diagnose, treat, cure, or prevent any disease, illness or medical condition. Constance CBD makes no healing, curative or medical claims or warranties regarding its products. If you have a medical condition or illness, please consult your physician.